Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004081240 | SCV003530685 | uncertain significance | not specified | 2022-12-19 | criteria provided, single submitter | clinical testing | The c.215G>A (p.R72Q) alteration is located in exon 2 (coding exon 2) of the LIMS2 gene. This alteration results from a G to A substitution at nucleotide position 215, causing the arginine (R) at amino acid position 72 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003134691 | SCV003814654 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2W | 2023-04-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003134691 | SCV004354232 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2W | 2022-11-10 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 70 of the LIMS2 protein (p.Arg70Gln). This variant is present in population databases (rs200231493, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with LIMS2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). |